Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,12,093 Cr
Revenue (TTM)
₹11,516 Cr
Net Profit (TTM)
₹1,911 Cr
ROE
26.5 %
ROCE
27.3 %
P/E Ratio
58.6
P/B Ratio
14.8
Industry P/E
37.52
EV/EBITDA
30.6
Div. Yield
1 %
Debt to Equity
0.4
Book Value
₹224.3
EPS
₹56.5
Face value
5
Shares outstanding
338,445,440
CFO
₹19,863.76 Cr
EBITDA
₹24,398.23 Cr
Net Profit
₹11,647.94 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Torrent Pharma
| -1.1 | 5.4 | 2.8 | 15.0 | 31.1 | 23.3 | 17.5 |
|
BSE Sensex
| 6.8 | 1.6 | 14.2 | 4.4 | 15.5 | 17.9 | 11.5 |
|
BSE Healthcare
| -1.6 | 2.9 | 13.2 | 16.2 | 26.3 | 22.3 | 10.1 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Torrent Pharma
| 46.3 | 48.7 | -5.4 | 17.3 | 52.0 | 4.1 | 27.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Torrent Pharma
|
3,324.5 | 1,12,093.1 | 11,516.1 | 1,911.3 | 25.4 | 26.5 | 58.6 | 14.8 |
| 34,050.0 | 72,685.4 | 6,409.2 | 1,414.4 | 25.3 | 36.5 | 51.4 | 17.2 | |
| 4,788.0 | 58,125.3 | 12,964.5 | 2,216.0 | 16.6 | 18.4 | 26.8 | 4.8 | |
| 1,141.4 | 66,228.8 | 31,723.7 | 3,515.3 | 15.5 | 11 | 19 | 2.0 | |
| 1,488.7 | 1,19,910.7 | 27,547.6 | 5,291.1 | 21.9 | 18.3 | 22.7 | 3.9 | |
| 1,281.0 | 1,06,747.2 | 32,643.9 | 5,725.2 | 20.7 | 18.6 | 18.9 | 3.2 | |
| 1,923.5 | 87,714.6 | 22,707.9 | 3,306.3 | 18.0 | 20 | 26.7 | 5.1 | |
| 2,420.3 | 99,539.9 | 12,279.3 | 1,998.9 | 19.6 | 16 | 50 | 6.9 | |
| 1,665.7 | 3,98,253.6 | 52,578.4 | 10,980.1 | 23.3 | 16.2 | 36.4 | 5.5 | |
| 974.1 | 97,906.6 | 23,241.5 | 4,614.8 | 26.2 | 20.4 | 21.6 | 4.1 |
2 min read•By Mohammed Ekramul Haque
Which stocks are vulnerable to Brexit?
4 min read•By Kumar Shankar Roy
3 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque
2 min read•By Vikas Vardhan
4 min read•By Saurabh Mukherjea
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various... therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited. Read more
Incorporated
1972
Chairman
Samir Mehta
Managing Director
--
Group
Torrent
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Torrent Pharmaceuticals Ltd stood at ₹ 14,396 Cr as on 31-Mar-25
The share price of Torrent Pharmaceuticals Ltd is ₹3,324.50 (NSE) and ₹3,324.10 (BSE) as of 08-Jul-2025 13:04 IST. Torrent Pharmaceuticals Ltd has given a return of 31.13% in the last 3 years.
Torrent Pharmaceuticals Ltd has a market capitalisation of ₹ 1,12,093 Cr as on 08-Jul-2025. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Torrent Pharmaceuticals Ltd is 14.77 times as on 08-Jul-2025, a 167% premium to its peers’ median range of 5.53 times.
The P/E ratio of Torrent Pharmaceuticals Ltd is 58.65 times as on 08-Jul-2025, a 56% premium to its peers’ median range of 37.52 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Torrent Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
The promoter of Torrent Pharmaceuticals Ltd is TORRENT INVESTMENTS LIMITED (FORMERLY KNOWN AS TORRENT INVESTMENTS PRIVATE LIMITED). TORRENT INVESTMENTS LIMITED (FORMERLY KNOWN AS TORRENT INVESTMENTS PRIVATE LIMITED) owns 68.31 per cent of the total equity. The chairman of the company is Samir Mehta ..
There is no promoter pledging in Torrent Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
4,02,284
|
|
|
1,22,253
|
|
|
1,08,921
|
|
|
1,00,724
|
|
|
1,00,677
|
|
|
90,286
|
|
|
73,834
|
|
|
69,150
|
|
|
58,405
|
| Torrent Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
26.46
|
|
Operating margin(%)
|
25.26
|
|
Net Margin(%)
|
16.54
|
|
Dividend yield(%)
|
0.99
|
Yes, TTM profit after tax of Torrent Pharmaceuticals Ltd was ₹1,911 Cr.
₹-27.80
(
